148 related articles for article (PubMed ID: 2250368)
21. Malignant pleural mesothelioma: two cases in first degree relatives.
Wilkins A; Popat S; Hughes S; O'Brien M
Lung Cancer; 2007 Sep; 57(3):407-9. PubMed ID: 17400330
[TBL] [Abstract][Full Text] [Related]
22. Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study.
Byrne MJ; Davidson JA; Musk AW; Dewar J; van Hazel G; Buck M; de Klerk NH; Robinson BW
J Clin Oncol; 1999 Jan; 17(1):25-30. PubMed ID: 10458214
[TBL] [Abstract][Full Text] [Related]
23. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
[TBL] [Abstract][Full Text] [Related]
24. Response of a patient with pleural and peritoneal mesothelioma after second-line chemotherapy with lipoplatin and gemcitabine.
Karpathiou G; Argiana E; Koutsopoulos A; Froudarakis ME
Oncology; 2007; 73(5-6):426-9. PubMed ID: 18523361
[TBL] [Abstract][Full Text] [Related]
25. A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma.
Berghmans T; Lafitte JJ; Paesmans M; Stach B; Berchier MC; Wackenier P; Lecomte J; Collon T; Mommen P; Sculier JP;
Lung Cancer; 2005 Oct; 50(1):75-82. PubMed ID: 16005104
[TBL] [Abstract][Full Text] [Related]
26. Malignant mesothelioma in an adolescent boy.
Varan A; Kara A; Haliloğlu M; Büyükpamukçu M; Ayhan A; Ruacan S
Pediatr Int; 1999 Dec; 41(6):693-5. PubMed ID: 10618893
[No Abstract] [Full Text] [Related]
27. [Cisplatin and cytosine arabinoside (ARA-C) for the therapy of primary and secondary pleural neoplasms].
Aitini E; Cavazzini G; Cantore M; Rabbi C; Smerieri F
G Ital Oncol; 1990; 10(3):85-8. PubMed ID: 2286397
[TBL] [Abstract][Full Text] [Related]
28. Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.
Chahinian AP; Antman K; Goutsou M; Corson JM; Suzuki Y; Modeas C; Herndon JE; Aisner J; Ellison RR; Leone L
J Clin Oncol; 1993 Aug; 11(8):1559-65. PubMed ID: 8336195
[TBL] [Abstract][Full Text] [Related]
29. Topotecan and pegylated liposomal doxorubicin combination as palliative treatment in patients with pretreated advanced malignant pleural mesothelioma.
Trafalis DT; Alifieris C; Krikelis D; Tzogkas N; Stathopoulos GP; Athanassiou AE; Sitaras NM
Int J Clin Pharmacol Ther; 2012 Jul; 50(7):490-9. PubMed ID: 22578202
[TBL] [Abstract][Full Text] [Related]
30. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.
Rusch VW; Niedzwiecki D; Tao Y; Menendez-Botet C; Dnistrian A; Kelsen D; Saltz L; Markman M
J Clin Oncol; 1992 Jun; 10(6):1001-6. PubMed ID: 1588364
[TBL] [Abstract][Full Text] [Related]
31. High liposomal doxorubicin tumour tissue distribution, as determined by radiopharmaceutical labelling with (99m)Tc-LD, is associated with the response and survival of patients with unresectable pleural mesothelioma treated with a combination of liposomal doxorubicin and cisplatin.
Arrieta O; Medina LA; Estrada-Lobato E; Ramírez-Tirado LA; Mendoza-García VO; de la Garza-Salazar J
Cancer Chemother Pharmacol; 2014 Jul; 74(1):211-5. PubMed ID: 24817602
[TBL] [Abstract][Full Text] [Related]
32. Randomized trial of doxorubicin versus cyclophosphamide in diffuse malignant pleural mesothelioma.
Sørensen PG; Bach F; Bork E; Hansen HH
Cancer Treat Rep; 1985 Dec; 69(12):1431-2. PubMed ID: 3907825
[TBL] [Abstract][Full Text] [Related]
33. Primary diffuse pleural rhabdomyosarcoma in an adult patient.
Koksal D; Ibrahimov F; Bugdayci M; Gedikoglu G; Emri S
Asian Cardiovasc Thorac Ann; 2016 Jan; 24(1):98-100. PubMed ID: 26207004
[TBL] [Abstract][Full Text] [Related]
34. Pemetrexed-cisplatin combination in mesothelioma.
Reck M; Gatzemeier U
Expert Rev Anticancer Ther; 2005 Apr; 5(2):231-7. PubMed ID: 15877521
[TBL] [Abstract][Full Text] [Related]
35. Fine-needle aspiration biopsy of pleural metastases from a carcinosarcoma or true malignant mixed tumor of the parotid gland mimicking a mesothelioma.
Khadse P; Prabhash K; Pramesh CS; Chaturvedi P; Shet T
Diagn Cytopathol; 2009 Sep; 37(9):680-5. PubMed ID: 19373913
[TBL] [Abstract][Full Text] [Related]
36. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial.
Rusch VW; Figlin R; Godwin D; Piantadosi S
J Clin Oncol; 1991 Feb; 9(2):313-9. PubMed ID: 1988578
[TBL] [Abstract][Full Text] [Related]
37. Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesothelioma.
van Ruth S; Baas P; Haas RL; Rutgers EJ; Verwaal VJ; Zoetmulder FA
Ann Surg Oncol; 2003 Mar; 10(2):176-82. PubMed ID: 12620914
[TBL] [Abstract][Full Text] [Related]
38. Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access program.
Obasaju CK; Ye Z; Wozniak AJ; Belani CP; Keohan ML; Ross HJ; Polikoff JA; Mintzer DM; Monberg MJ; Jänne PA;
Lung Cancer; 2007 Feb; 55(2):187-94. PubMed ID: 17092602
[TBL] [Abstract][Full Text] [Related]
39. Complete response and long-term survival in malignant pleural mesothelioma: case report.
Takanen S; Resuli B; Graziano V; Parisi A; Lisi R; Raffetto N; Tombolini V
Anticancer Res; 2012 Apr; 32(4):1485-7. PubMed ID: 22493390
[TBL] [Abstract][Full Text] [Related]
40. A case of repetitive intrapleural cancer chemotherapy using INFUSE-A-PORT for malignant mesothelioma.
Omasa M; Hirata T; Shoji T; Bando T; Hasegawa S; Inui K; Wada H
Thorac Cardiovasc Surg; 2001 Aug; 49(4):233-5. PubMed ID: 11505321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
